ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #5,155Hybrid

Molecular Immunology

Acronym:mimm
•
Abbreviation (ISO):MOL. IMMUNOL
•
Identifier (ISSN):0161-5890(Print)/1872-9142(Online)
•
Publisher:Elsevier Ltd
Clarivate IF (2026)
3.7↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Molecular Immunology

WoS Q2
23563.1920183.0620193.6420204.4120214.1720223.620233.22024320253.72026
Annual Impact Factor Metric
Current (2026):3.7
Scopus SJR & RankScopus Q2
0.969
#5,155

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
160

160 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
294articles/year
25.61% Gold OA•95.63% Original Research

Aims & Scope

Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to: Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunology Mechanisms of induction, regulation and termination of innate and adaptive immunity Intercellular communication, cooperation and regulation Intracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc) Mechanisms of action of the cells and molecules of the immune system Structural analysis Development of the immune system Comparative immunology and evolution of the immune system "Omics" studies and bioinformatics Vaccines, biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc) Technical developments.

Topics Covered (Recognized by AI)
Biology93.2%Genetics88.8%Chemistry86.6%Medicine86.1%Biochemistry80.3%Immunology79%Gene53.2%Internal medicine51.2%Antibody48.7%Immune system46.2%Molecular biology34.8%Antigen32.7%Cell biology32.4%Physics28.7%Organic chemistry23.1%Receptor22.8%Nuclear magnetic resonance20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q2
Rank153/328
IndexSCIE
JCRSCIE2026

IMMUNOLOGY

Q2
Rank85/183
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q2
Rank131/328
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q2
Rank86/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.7
Articles / Year134
Total Citations38
2025
IF3
Articles / Year214
Total Citations586
2024
IF3.2
Articles / Year143
Total Citations859
2023
IF3.6
Articles / Year180
Total Citations1,752
2022
IF4.174
Articles / Year326
Total Citations2,537

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,155Scopus Q2SCImago Profile
Scopus Coverage:1975, 1977-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology
Scopus Citation Rank (SJR)Q2
0.969

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.56

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,291 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,853
3-Year Documents520
Citable Documents513

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Molecular BiologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Immunology (acronym: mimm, abbr: MOL. IMMUNOL, ISSN: 0161-5890) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in England since 1979. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.969 (Q2), an H-index of 160.

The journal enforces rigorous peer evaluation with an average review speed of 7.2周, a publication frequency of Semimonthly, an annual output of approximately 294 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,291 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Ltd
Publication Language
Multi-Language
Frequency
Semimonthly
Founding Year
1979
Indexing & Databases
SCIEScopusPubMed
Editorial Address
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ca8e8bea-27a6-4da0-9ff2-95298574323a
Database Updated: 2026-10-16